DB17723InvestigationalGene Therapies
RP-L102 is a lentiviral vector carrying the Fanconi Anemia-A (FANCA) gene currently being developed by Rocket Pharmaceuticals for the treatment of Fanconi anemia type A.
- Also known as
- Autologous CD34+ HSPCs Transduced with LV Carrying FANCA Gene RP · Autologous CD34+-enriched Hematopoietic Stem and Progenitor Cells Transduced with Lentiviral Vector Carrying FANCA Gene RP-L102 · Autologous CD34+-enriched HSPCs Transduced with Lentiviral Vector Carrying FANCA Gene RP-L102 · RP L102 · RP-L102
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Mozafancogene autotemcel, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account